Trauma healing shouldn't be a solo battle. Explore a three-level map: inner parts, relationships, and meaning, to know when ...

Once deployed, a challenge arises: people don’t use systems because they don’t trust them. Arionkoder solves this by ...

Arionkoder, the AI consulting firm, will be at ViVE 2026, Feb. 22–25 in Los Angeles, to discuss business demands and ...

Tanmay Bhat has hit a roadblock with his GLP-1 medication. The comedian shared that he is experiencing zero appetite ...

An informational overview of Ivím Health's compounded semaglutide and tirzepatide telehealth program, including GLP-1 ID cost breakdown, weekly provider check-in structure, clinical claims analysis, a ...

Health informatics leaders at NYU Langone Health think fully autonomous clinical AI is coming in the next five years or so, ...

As integrated health technologies increasingly shape the future of heart failure management, this paper provides ...

A 2026 Informational Overview of the BreezeMeds Compounded GLP-1 Telehealth Weight Loss Platform, Semaglutide and Tirzepatide Medication Formats, Published Pricing Structure, 503A Compounding Pharmacy ...

Dr. Paul A. Testa, CHIO at NYU Langone Health, says artificial intelligence demands the same level of institutional commitment, governance and cultural investment that the best health systems brought ...

A virtual assistant powered by AI supervised by a cardiologist can offer guideline-directed medical therapy optimization after hospitalization for heart failure with reduced ejection fraction.

A single reusable pen could make costly GLP-1 therapy more affordable and accessible for millions of Indians battling diabetes and obesity.

Losing weight with the help of a prescription weight loss drug continues to increase in popularity. According to recent KFF polls, about one in eight U.S. adults takes a GLP-1 medication for ...